A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy;
Alsuliman, A, Appel, SH, Beers, DR, Basar, R, Shaim, H, Kaur, I, Zulovich, J, Yvon, E, Muftuoglu, M, Imahashi, N, Kondo, K, Liu, E, Shpall, EJ & Rezvani, K 2016, Cytotherapy, vol 18, no. 10, pp. 1312-24. DOI:

Aspiration Thrombectomy after Intravenous Alteplase Versus Intravenous Alteplase Alone;
Mocco, J, Zaidat, OO, Von Kummer, R, Yoo, AJ, Gupta, R, Lopes, D, Frei, D, Shownkeen, H, Budzik, R, Ajani, ZA, Grossman, A, Altschul, D, McDougall, C, Blake, L, Fitzsimmons, BF, Yavagal, D, Terry, J, Farkas, J, Lee, SK, Baxter, B, Wiesmann, M, Knauth, M, Heck, D, Hussain, S, Chiu, D, Alexander, MJ, Malisch, T, Kirmani, J, Miskolczi, L & Khatri, P 2016, Stroke, vol 47, no. 9, pp. 2331-2338. DOI:

Analyzing tumor heterogeneity and driver genes in single myeloid leukemia cells with SBCapSeq;
Mann, KM, Newberg, JY, Black, MA, Jones, DJ, Amaya-Manzanares, F, Guzman-Rojas, L, Kodama, T, Ward, JM, Rust, AG, Van Der Weyden, L, Yew, CCK, Waters, JL, Leung, ML, Rogers, K, Rogers, SM, Mcnoe, LA, Selvanesan, L, Navin, N, Jenkins, NA, Copeland, NG & Mann, MB 2016, Nature Biotechnology, vol 34, no. 9, pp. 962-972. DOI:

Correlating mammographic and pathologic findings in clinical decision support using natural language processing and data mining methods;
Patel, TA, Puppala, M, Ogunti, RO, Ensor, Jr. JE, He, T, Shewale, JB, Ankerst, DP, Kaklamani, VG, Rodriguez, AA, Wong, STC & Chang, JC 2016, Cancer. DOI:

HOXC10 expression supports the development of chemotherapy resistance by fine tuning DNA repair in breast cancer cells;
Sadik, H, Korangath, P, Nguyen, NK, Gyorffy, B, Kumar, R, Hedayati, M, Teo, WW, Park, S, Panday, H, Munoz, TG, Menyhart, O, Shah, N, Pandita, RK, Chang, JC, DeWeese, T, Chang, HY, Pandita, TK & Sukumar, S 2016, Cancer Research, vol 76, no. 15, pp. 4443-4456. DOI:

Stem cells in amyotrophic lateral sclerosis: Ready for prime time?;
Appel, SH & Armon, C 2016, Neurology, vol 87, no. 4, pp. 348-349. DOI:

A recellularized human colon model identifies cancer driver genes;
Chen, HJ, Wei, Z, Sun, J, Bhattacharya, A, Savage, DJ, Serda, R, Mackeyev, Y, Curley, SA, Bu, P, Wang, L, Chen, S, Cohen-Gould, L, Huang, E, Shen, X, Lipkin, SM, Copeland, NG, Jenkins, NA & Shuler, ML 2016, Nature Biotechnology, vol 34, no. 8, pp. 845-851. DOI:

Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion;
Mazumdar, A, Poage, GM, Shepherd, J, Tsimelzon, A, Hartman, ZC, Den Hollander, P, Hill, J, Zhang, Y, Chang, J, Hilsenbeck, SG, Fuqua, S, Kent Osborne, C, Mills, GB & Brown, PH 2016, Breast Cancer Research and Treatment, pp. 1-14. DOI:

Pluripotent stem cells and DNA damage response to ionizing radiations;
Mujoo, K , Butler, EB, Pandita, RK, Hunt, CR & Pandita, TK 2016, Radiation Research, vol 186, no. 1, pp. 17-26. DOI:

Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: Results from a phase Ib/IIa study;
Martin, M, Fumoleau, P, Dewar, JA, Albanell, J, Limentani, SA, Campone, M, Chang, JC, Patre, M, Strasak, A, de Haas, SL, Xu, J & Garcia-Saenz, JA 2016, Annals of Oncology, vol 27, no. 7, mdw157, pp. 1249-1256. DOI: